-

Class Action Update: Robbins LLP Reminds Investors that TaskUs, Inc. (TASK) is Being Sued by Shareholders

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP reminds investors that a class action has been filed on behalf of persons and entities that purchased or acquired TaskUs, Inc. (NASDAQ: TASK) securities between June 11, 2021 and January 19, 2022, for violations of the Securities Exchange Act of 1934. TaskUs provides outsourcing services for companies worldwide.

If you would like more information about our investigation of TaskUs, Inc.'s misconduct, click here.

What is this Case About: TaskUs, Inc. (TASK) Misstated its Business Prospects

According to the complaint, TaskUs held its initial public offering ("IPO") on June 10, 2021, offerings its shares at $23 per share. In the offering documents for the IPO, TaskUs claimed to have "industry-leading growth and profitability" and insisted that its "market opportunity is over $100 billion." During the class period, TaskUs continued to assert that its "market opportunity … is simply massive," and the "market across the specialized services we deliver is over $100 billion, and demand for some of these services is growing up to 50% annually. So we are just getting started."

These statements, however, were materially false and misleading. Actually, TaskUs was experiencing severe financial strain and business challenges, especially with its most important customer, Facebook. Further, defendants' representations were based on outdated market data and improperly recognized revenue from certain key contracts. Finally, defendants outstated the size of TaskUs' workforce and understated employee retention and attrition rates.

On January 20, 2022, Spruce Point Capital Management, LLC issued a short-seller report on TaskUs. In the report, Spruce Point states, "After conducting a forensic financial and accounting review, Spruce Point believes shares of TaskUs, Inc. (Nasdaq: TASK) … has a pattern of exaggerated and inflated business claims, including revenue, and is covering-up financial strain with reduced disclosures, cherry-picked market data, and non-standard key performance metrics." The report notes the shortcomings of its CEO, CFO, and Principal Accounting Officer, and issues with its financial assumptions and presentation methods, among other things. On this news, TaskUs's stock fell $5.46, or over 15%, to close at $30.13 per share on January 20, 2022, injuring investors.

Next Steps: If you purchased shares of TaskUs, Inc. (TASK) between June 11, 2021 and January 19, 2022, you have until April 25, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against TaskUs, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:TASK

Release Summary
Class Action Update: Robbins LLP Reminds Investors that TaskUs, Inc. (TASK) is Being Sued by Shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Did You Lose Money in Stride, Inc.? Contact Robbins LLP for Information About Your Rights Against LRN.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: The company: Stride, Inc. (NYSE: LRN) is a technology company that provides an education platform to deliver online learning to students throughout the U.S. What is the class period? October 22, 2024 - October 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stride during the class period because the Company allegedly misled investors regarding i...

Did You Lose Money in Perrigo Company? PRGO Stockholders Should Contact Robbins LLP for Information About Their Rights Against PRGO.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally. What is the class period? February 27, 2024 - November 4, 2025 What is the Case About? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who acquired Perrigo securities during the class period because the Company allegedly misled investors regarding the value of its infant formula...

Did You Suffer Financial Loss in Skye Bioscience, Inc.? Stockholders Should Contact Robbins LLP for Information About Their Rights Against SKYE.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, overweight, and metabolic diseases. The Company’s lead product candidate is nimacimab. What is the class period? November 4, 2024 - October 3, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors...
Back to Newsroom